| Written | 2019-04 | Mary J Underdown, Thomas B Russell, Mark J Pettenati, David E Kram. |
| Department of Pediatrics, Wake Forest School of Medicine, Winston Salem, North Carolina (MJU); Section of Pediatric Hematology-Oncology, Department of Pediatrics, Wake Forest School of Medicine, Winston Salem, North Carolina (DEK, TBR); Department of Pathology, Wake Forest School of Medicine, Winston Salem, USA (MJP), Medical Center Boulevard, Winston Salem, NC, USA 27157; dkram@wakehealth.edu |
| This article is an update of : |
| 2005-09 | Sabine Strehl | |
| Children's Cancer Research Institute, Kinderspitalgasse 6, A-1090 Vienna, Austria |
| Abstract | Dicentric (7;9)(p11-13;p11) is a rare but recurrent abnormality in pediatric and adult precursor B acute lymphoblastic leukemia (B-ALL). The rarity precludes a deep understanding of its biology and associated prognosis. However, recent findings have correlated dic(7;9) and PAX5 mutations, highlighting this cytogenetic event's involvement in leukemogenesis and may also shed light on the overall prognosis of dic(7;9) B-ALL. |
| Keywords | Acute lymphoblastic leukemia, dicentric translocation, PAX5, chromosome 7, chromosome 9. |
| Identity |
| ICD-Topo | C420,C421,C424 BLOOD, BONE MARROW, & HEMATOPOIETIC SYS |
| ICD-Morpho | 9811/3 B lymphoblastic leukaemia/lymphoma, NOS |
| Atlas_Id | 1054 |
 | |
| Figure 1: dic(7;9)(p11-13;p11) G-banding - Courtesy Cytogenetics Laboratory of the CCRI, Children's Cancer Research Institute, Vienna. | |
| Clinics and Pathology |
| Disease | ALL |
| Phenotype / cell stem origin | FAB L1 phenotype; pre-B immunophenotype, cIg+ or cIg- |
| Epidemiology | There have been 36 cases of dic(7;9)(p11-13;p11) currently identified in the literature, 17 (47.2%) of which are pediatric cases. This rare translocation makes up < 1% of childhood ALL, It is most commonly found in younger children, age ≤ 6 years; dic(7;9)(p11-13;p11) is found in approximately 3% of childhood ALL with 9p abnormalities and has been associated with B-ALL with t(9;22), or Philadelphia chromosome positive ALL. |
| Clinics | The most common clinical manifestations of dic(7;9) noted in the literature include age <15 years, male > female, T- and B-ALL with B-cell predominance, leukocytosis <100x109, enlargement of liver/spleen/lymph nodes (Pan and Xue, 2006). |
| Prognosis | Favorable prognostic indicators in ALL include: age 1-10 years, female sex, Caucasian or Asian ethnicity, WBC count <50,000 at presentation, B-cell immunophenotype, hyperdiploidy, and trisomy of chromosome 4 or 10. The most important prognostic factor is end of induction therapy minimal residual disease (MRD) (Hunger and Mullighan, 2015; Iacobucci and Mullighan, 2017). However, abnormalities in chromosome 9p or deletions of the tumor suppressor genes located on 7p have been associated with increased rates of relapse (Jarosova and Volejnikova, 2016), and may even potentially trump favorable NCI criteria or other favorable cytogenetics. |
| Cytogenetics |
| Note | Several dicentric chromosomes found in childhood ALL are formed from the q arms of chromosomes 7, 9, 12, and, 17 with partial loss of the respective p arms. |
| Cytogenetics Morphological | Unbalanced; In most cases, formation of a dicentric chromosome resulting in partial monosomies of 7p and 9p -> hypodiploid with 45 chromosomes. However, hyperdiploidy (56 chromosomes) has been identified. |
 | |
| Figure 2: FISH image depicting 7; dic 7-9; 9 with centromeric probes of 7 and 9 fused - Courtesy Department of Pathology, Wake Forest School of Medicine, Winston Salem, USA. | |
| Additional anomalies | del(6q), dup(1p), del(8p),... |
| Genes involved and Proteins |
| Note | Genes involved are unknown. |
| Gene Name | PAX5 |
| Location | 9p13.2 |
| Note | Recent studies have shown an association between dic(7;9) and PAX5 mutation. PAX5 encodes the B lymphoid transcription factor gene and is vitally important in regulating B cell lineage differentiation. PAX5 alterations may lead to arrested B-cell development in the pro-B-cell stage and may be central events in B lymphoid leukemogenesis (Shah and Schrader, 2013). A recent study by Bastian, et. al. found 19/250 pediatric and adult patients with B-cell precursor ALL harbored PAX5 mutations. Of these patients with PAX5 mutations, 12/19 (63%) had alterations in chromosome 9, though the specific cytogenetic alterations were not reported (Bastian and Schroeder, 2019). A large cohort study out of St. Jude's identified 17/1988 (0.86%) patients with dic(7;9) translocation; of those, 11/17 (65%) had a PAX5 alteration or mutation. While the PAX5 gene is located on 9p13.2, 5/11 (45%) cases with dic(7;9)(p11;p11) were associated with PAX5 alterations. This study found two distinct subtypes of B-ALL characterized by PAX5 alterations: the first (n=148) which harbor diverse PAX5 alterations (including rearrangements, sequence mutations, and focal intragenic amplifications) and the second (n=44) which harbor a particular nonsilent sequence mutation, PAX5 p.Pro80Arg. As a group of all PAX5, the 5-year event-free survival was variable, ranging from 50% to 75% (Gu and Churchman, 2019). |
| To be noted |
| Notable Case from Wake Forest School of Medicine, Winston Salem, USA: An 8-year-old male with no previous history of malignancy presented with pancytopenia and was diagnosed with B-cell ALL. He had multiple favorable clinical and cytogenetic prognostic factors at diagnosis, including favorable age, low WBC (4.0) at presentation, CNS negative, B-phenotype, double trisomy, hyperdiploidy, and end-of-induction MRD negative. His blasts also carried a dic(7;9)(p11;p11). Despite the plethora of favorable prognostic factors, he has had two relapses, and is now in his third complete remission after chimeric antigen receptor T cell therapy. While it is not known whether his somatic mutation involved the PAX5 gene, his multiple relapses and poor overall prognosis may be related to this dic(7 ;9) event. | |
| Case Report | Dicentric dic(7;9)(p11;p11): a new case in childhood ALL |
| Bibliography |
| Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Groupe Français de Cytogénétique Hématologique (GFCH). |
| Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 1993 ; 7 (1) : 10-19. |
| PMID 8418369 |
| PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia. |
| Bastian L., Schroeder, M. P., Eckert, C., Schlee, C., Tanchez, J. O., Kämpf, S. Baldus, C. D. |
| Leukemia 2019 |
| PMID 30842609 |
| Deletions of interferon genes in acute lymphoblastic leukemia. |
| Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, Le Beau MM, Rowley JD |
| The New England journal of medicine. 1990 ; 322 (2) : 77-82. |
| PMID 2294436 |
| PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia |
| Gu, Z., Churchman, M. L., Roberts, K. G., Moore, I., Zhou, X., Nakitandwe, J. Mullighan, C. G. |
| Nature Genetics 2019; 51(2): 296-307. |
| PMID 30643249 |
| Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group. |
| Heerema NA, Nachman JB, Sather HN, La MK, Hutchinson R, Lange BJ, Bostrom B, Steinherz PG, Gaynon PS, Children's Cancer Group, Uckun FM |
| Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2004 ; 18 (5) : 939-947. |
| PMID 14999294 |
| Acute Lymphoblastic Leukemia in Children. |
| Hunger SP, Millighan CG. |
| N Engl J Med 2015; 373(16): 1541-1552 |
| PMID 26465987 |
| Genetic Basis of Acute Lymphoblastic Leukemia. |
| Iacobucci I, Mullighan CG. |
| J Clin Oncol 2017; 35(9): 975-983. |
| PMID 28297628 |
| Chromosomal abberations in childhood acute lymphoblastic leukemia: 15-year single center experience. |
| Jarosova M, Volejnikova J, Porizkova I, Holzerova M, Pospisilova D, Novak Z, Vrbkova J, Mihal V. |
| Cancer Genetics 2016; 209(7-8): 340-347. |
| PMID 27341996 |
| Screening for specific chromosome involvement in hematological malignancies using a set of seven chromosome painting probes. An alternative approach for chromosome analysis using standard FISH instrumentation. |
| Nacheva EP, Gribble S, Andrews K, Wienberg J, Grace CD |
| Cancer genetics and cytogenetics. 2000 ; 122 (2) : 65-72. |
| PMID 11106813 |
| Dicentric (7;9)(p11;p11) is a rare but recurrent abnormality in acute lymphoblastic leukemia: a study of 7 cases. |
| Pan J, Xue Y, Wu Y, Wang Y, Shen J. |
| Cancer genetics and cytogenetics 2006; 169(2): 159-163. |
| PMID 16938575 |
| Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia. |
| Raimondi SC, Zhou Y, Mathew S, Shurtleff SA, Sandlund JT, Rivera GK, Behm FG, Pui CH |
| Cancer. 2003 ; 98 (12) : 2715-2722. |
| PMID 14669294 |
| A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. |
| Shah, S., Schrader, K. A., Waanders, E., Timms, A. E., Vijai, J., Miething, C. Offit, K. |
| Nature Genetics 2013; 45(10), 1226-1231. |
| PMID 24013638 |
| Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience. |
| Thomas X, Olteanu N, Charrin C, Lhéritier V, Magaud JP, Fiere D |
| American journal of hematology. 2001 ; 67 (2) : 73-83. |
| PMID 11343378 |
| Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. |
| Uckun FM, Nachman JB, Sather HN, Sensel MG, Kraft P, Steinherz PG, Lange B, Hutchinson R, Reaman GH, Gaynon PS, Heerema NA |
| Cancer. 1998 ; 83 (9) : 2030-2039. |
| PMID 9806664 |
| Detection of chromosome over- and underrepresentations in hyperdiploid acute lymphoblastic leukemia by comparative genomic hybridization. |
| Wong N, Chen SJ, Cao Q, Su XY, Niu C, Wu QW, Leung TW, Wickham N, Johnson PJ, Chen Z |
| Cancer genetics and cytogenetics. 1998 ; 103 (1) : 20-24. |
| PMID 9595040 |
| Citation |
| This paper should be referenced as such : |
| Mary J Underdown, Thomas B Russell, Mark J Pettenati, David E Kram |
| dic(7;9)(p11-13;p11) |
| Atlas Genet Cytogenet Oncol Haematol. 2019;23(10):320-322. |
| Free journal version : [ pdf ] [ DOI ] |
| On line version : http://AtlasGeneticsOncology.org/Anomalies/dic0709p11p11ID1054.html |
| History of this paper: |
| Strehl, S. dic(7;9)(p11-13;p11). Atlas Genet Cytogenet Oncol Haematol. 2006;10(2):110-111. |
| http://documents.irevues.inist.fr/bitstream/handle/2042/38299/09-2005-dic0709p11p11ID1054.pdf |
| Translocations implicated (Data extracted from papers in the Atlas) |
| dic(7;9)(p11;p11) | |
| External links |
| Mitelman database | dic(7;9)(p11;p11) |
| arrayMap (UZH-SIB Zurich) | Topo ( C42) Morph ( 9811/3) - [auto + random 100 samples .. if exist ] [tabulated segments] |
| REVIEW articles | automatic search in PubMed |
| Last year articles | automatic search in PubMed |
| All articles | automatic search in PubMed |
| © Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Fri Oct 8 16:35:24 CEST 2021 |
For comments and suggestions or contributions, please contact us